線粒體融合蛋白Mfn2抗體,Anti-Mitofusin 2相關產品：
Anti-NHE1抗體說明書，鈉氫通道蛋白抗體
Anti-NIK/MAPKKK14抗體說明書，NFkB誘導激酶抗體
Anti-NIS抗體說明書，鈉碘轉運體蛋白抗體
Anti-NIT2 抗體說明書，抗NIT2蛋白抗體
Anti-NK-1/Substance P Receptor抗體說明書，P物質受體抗體
Anti-NK-2R抗體說明書，神經激肽A受體/K物質受體抗體
Anti-NKA抗體說明書，神經激肽A抗體
Anti-NKB 抗體說明書，神經激肽B抗體
Anti-NKG2A/CD159a/KLRC1抗體說明書，自然殺傷細胞活化性受體2A抗體
Anti-NKG2C抗體說明書， NK細胞受體2C/自然殺傷細胞活化性受體2C抗體
Anti-NKG2D/CD314/KLRK1抗體說明書，NK細胞受體/自然殺傷細胞活化性受體抗體
Anti-NKR抗體說明書，神經激肽B受體抗體
Anti-NKR/Neurokin B receptor抗體說明書，神經激肽-B受體抗體
Anti-Nm23抗體說明書，腫瘤轉移抑制基因抗體
Anti-Nm23-H1抗體說明書，腫瘤抑制基因抗體
線粒體融合蛋白Mfn2抗體,Anti-Mitofusin 2Background: B-ATF is a nuclear basic leucine zipper protein that belongs to the
AP-1/ATF superfamily of transcription factors. The leucine zipper of B-ATF mediates
dimerization with members of the Jun family of proteins. The B-ATF protein does not
homodimerize efficiently, but rather forms a heterodimer preferentially with c-Jun. The
B-ATF/c-Jun protein complex can interact with DNA containing a consensus binding
site for AP-1, suggesting that B-ATF functions as a tissue-specific modulator of the
AP-1 transcription complex in human cells. B-ATF also associates with IFP35, a
leucine zipper protein that translocates to the nucleus following IFN treatment. The
gene encoding B-ATF, also designated SFA-2, is strongly expressed in mature T and
B lymphocytes, and is up-regulated after transformation by human T-cell leukemia
virus type I
線粒體融合蛋白Mfn2抗體,Anti-Mitofusin 2Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications
